Medicina, Dermatología y Toxicología
Departamento
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (5)
2024
-
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study
Journal of Clinical Medicine, Vol. 13, Núm. 6
-
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study
Journal of Clinical Medicine, Vol. 13, Núm. 14
-
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study
Lupus, Vol. 33, Núm. 7, pp. 663-674
2017
-
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2003
-
A comparison of primary care physicians and pneumologists in the management of asthma in Spain: ASES study
Respiratory Medicine, Vol. 97, Núm. 8, pp. 872-881